IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.181
EU - Europa 7.786
AS - Asia 2.810
SA - Sud America 378
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 9
Totale 19.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.655
RU - Federazione Russa 2.893
SG - Singapore 1.562
GB - Regno Unito 1.376
IT - Italia 1.247
DE - Germania 587
UA - Ucraina 582
CA - Canada 509
HK - Hong Kong 487
CN - Cina 337
BR - Brasile 333
DK - Danimarca 269
VN - Vietnam 264
SE - Svezia 224
IE - Irlanda 175
FI - Finlandia 121
NL - Olanda 85
FR - Francia 66
AT - Austria 38
PL - Polonia 38
ID - Indonesia 33
EU - Europa 27
PK - Pakistan 23
IN - India 15
BE - Belgio 14
RO - Romania 14
AR - Argentina 13
BD - Bangladesh 10
EC - Ecuador 10
ES - Italia 10
IQ - Iraq 10
LT - Lituania 9
MA - Marocco 9
CH - Svizzera 8
MX - Messico 8
TR - Turchia 8
AU - Australia 6
JP - Giappone 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
EG - Egitto 5
KG - Kirghizistan 5
MG - Madagascar 5
MT - Malta 5
TH - Thailandia 5
TW - Taiwan 5
VE - Venezuela 5
CL - Cile 4
CO - Colombia 4
IL - Israele 4
IR - Iran 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
UY - Uruguay 4
AM - Armenia 3
AZ - Azerbaigian 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
LK - Sri Lanka 1
MK - Macedonia 1
RS - Serbia 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
Totale 19.226
Salva come PNG Salva come JPEG
Città #
Southend 907
Chandler 733
Singapore 688
Fairfield 584
Houston 490
Woodbridge 468
San Mateo 436
Ann Arbor 422
Falls Church 406
Hong Kong 379
Seattle 335
Cambridge 331
Jacksonville 320
Wilmington 292
Moscow 268
Ashburn 260
Ottawa 251
Dearborn 214
The Dalles 207
Boardman 190
Dublin 173
Stevenage 164
Beauharnois 163
Portsmouth 163
Pisa 157
Beijing 152
Dong Ket 147
Lawrence 132
Milan 109
Rome 90
Montréal 72
Chicago 68
Los Angeles 62
San Diego 61
Santa Clara 61
Fremont 53
London 53
Helsinki 52
Munich 49
Nuremberg 39
Redwood City 39
Salt Lake City 39
Florence 38
Brooklyn 37
Warsaw 36
Dongguan 31
Old Bridge 27
Buffalo 26
Central District 26
Genoa 24
Lappeenranta 23
Norwalk 23
Lucca 22
Livorno 19
São Paulo 19
Vienna 19
Washington 19
Dallas 18
Tampa 17
Shenzhen 15
Assago 14
Brussels 14
Rio de Janeiro 14
Shanghai 14
Turin 14
Amsterdam 13
Bologna 13
Frankfurt am Main 13
Guangzhou 13
Serra 13
Naples 12
Toronto 11
Cascina 10
Lancaster 10
Brasília 9
Council Bluffs 9
Islamabad 9
Kilburn 9
Nanjing 9
Redmond 9
Bari 8
Chengdu 8
Elk Grove Village 8
Hanover 8
Mykolayiv 8
Palermo 8
Perugia 8
Buti 7
Iowa City 7
Laurel 7
Venice 7
Wandsworth 7
Bucharest 6
Foggia 6
Mumbai 6
Padova 6
Pescia 6
Sterling 6
Tashkent 6
Viareggio 6
Totale 11.089
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 367
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 277
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 211
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 206
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 205
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 197
Treating chemoreflex in heart failure: modulation or demolition? 197
B-type natriuretic peptide secretion following scuba diving 186
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 185
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 183
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 180
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 180
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 177
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 177
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 168
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 168
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 167
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 167
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 166
Prediction of the chemoreflex gain by common clinical variables in heart failure 165
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 159
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 158
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 155
Prognostic value of plasma Renin activity in heart failure. 154
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 152
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 152
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 152
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 151
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 151
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 149
Breathless heart: only when the neck is deep in water? 148
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. 146
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 146
A simple echocardiographic score to rule out cardiac amyloidosis 145
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 144
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 143
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 143
Adrenergic activation in heart failure: blockade or rebalance? 141
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. 140
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 140
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure 140
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 137
How to take arms against central apneas in heart failure 136
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 135
High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice 132
Plasma renin activity is an independent prognosticator in heart failure patients with kidney disease 130
An atypical case of cardiac amyloidosis. 129
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 128
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 128
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 128
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 126
The paradox of low BNP levels in obesity 123
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 123
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 122
Diabetes is a predictor of effort tolerance and ventilatory efficiency in patients with moderate systolic dysfunction on beta-blocker therapy 120
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 120
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 120
Funzione endocrina cardiaca nello scompenso determinanti clinici, neuroormonali ed emodinamici 118
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 116
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 115
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 114
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 114
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) 114
Recent knowledges on chemosensitivity to hypoxia and hypercapnia in cardiovascular disease. 112
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 112
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 112
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 111
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 111
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 111
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 108
Cheyne-Stokes respiration and heart failure: pathophysiologicaland clinical implications 107
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 107
Natruiretic peptides in heart failure. 106
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 106
OVEREXPRESSION OF ANG-(1-7) IMPROVES CARDIAC FUNCTION AND ATTENUATES LEFT VENTRICULAR REMODELING 105
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 105
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 105
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 104
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 103
Improved survival in limited scleroderma-related pulmonary artery hypertension 101
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 101
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 101
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 101
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 100
Management of complications of cardiac amyloidosis: 10 questions and answers 99
The Breathless Heart - Apneas in Heart Failure 99
Renin profiling predicts neurohormonal response to sacubitril/valsartan 99
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 98
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 97
Validity of transit time–based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers 95
Troponin in non-ischaemic dilated cardiomyopathy 94
Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial 94
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 94
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 94
Reply 94
A simple echocardiographic score to rule out cardiac amyloidosis 93
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 93
Use of hypocapnia for improved risk stratification in pulmonary arterial hypertension: should we return to respiratory pathophysiology? 93
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 92
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 91
Totale 13.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.745
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 0 0 0 0 0 45 50 190
2020/20213.396 277 365 154 306 167 542 330 217 177 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/20257.389 65 80 466 207 596 585 1.383 2.351 871 785 0 0
Totale 19.471